Faye Feller - Aug 15, 2023 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Medical Officer
Signature
/s/ Olivia Bloom for Faye Feller
Stock symbol
GERN
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/21/2023, 09:31 PM
Previous filing
Feb 24, 2023
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (right to buy) Award $0 +20K $0.00 20K Aug 15, 2023 Common Stock 20K $1.06 Direct F1
transaction GERN Employee Stock Option (right to buy) Award $0 +180K $0.00 180K Aug 15, 2023 Common Stock 180K $1.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on February 16, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.
F2 Performance-based stock option granted on July 8, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.